Impel NeuroPharma Company Profile
Based in Seattle, WA, Impel NeuroPharma is a medical device company whose Pressurized Olfactory Delivery technology enables pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system. Impel has internal product development programs targeting a variety of CNS diseases, including pain, Parkinsonâs, brain cancer, and AIDS-related dementia (neuroAIDS).
News Articles
UW Spinoff Impel Neuropharma Passes Key Nose-to-Brain Clinical Trial
Seattle-based Impel Neuropharma has been working for five years to show it can quickly deliver drugs through the nose, directly to the brain, for the treatment of central nervous system disorders. The...
Impel NeuroPharma announces important POD technology milestones
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a se...
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery,...
Impel NeuroPharma Completes Industry’s First Nose-to-Brain Human Imaging Study
Impel NeuroPharma announced today the completion of its human proof of concept study with the POD technology demonstrating nose-to-brain delivery using SPECT imaging, a first in t...
Seattle-based Impel Neurpharma, the developer of technology to deliver drugs to the brain, said today it has secured a two-year, $750,000 grant from the U.S. Department of Defense. The company, a Univ...
Drugs and Medications
None
PubMed Articles
Can UV Exposure Reduce Mortality?
A Swedish cohort analysis in this issue (1) demonstrates a significant reduction in all cause mortality and in cardiovascular mortality associated with several measures of sun exposure. In addition, u...
Transcriptional and epigenetic regulation of B cell development.
B cell development starts in the bone marrow where hematopoietic stem cells (HSCs) progress through sequential developmental stages, as it differentiates into a naïve B cell expressing surface immuno...
Clinical Trials
None
Companies
Based in Seattle, WA, Impel NeuroPharma is a medical device company whose Pressurized Olfactory Delivery technology enables pharmaceutical drugs to bypass the blood-brain barrier...
Maas Biolab is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, Alzhe...
More Information about "Impel NeuroPharma" on BioPortfolio
We have published hundreds of Impel NeuroPharma news stories on BioPortfolio along with dozens of Impel NeuroPharma Clinical Trials and PubMed Articles about Impel NeuroPharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Impel NeuroPharma Companies in our database. You can also find out about relevant Impel NeuroPharma Drugs and Medications on this site too.
